NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation

Cellular and Molecular Immunology

Volumn 13, Issue 4, 2016, Pages 535-550

  Jiao, Delong ^a   Wong, Chun Kwok ^a,b   Qiu, Huai Na ^a   Dong, Jie ^a   Cai, Zhe ^a   Chu, Man ^a   Hon, Kam Lun ^a   Tsang, Miranda Sin Man ^a,b   Lam, Christopher Wai Kei ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Atopic dermatitis; basophils; eosinophils; NOD2; TLR2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MURAMYL DIPEPTIDE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; CHEMOKINE; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BASOPHIL; CELL ACTIVATION; CELL CONTACT; CELL EXPANSION; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; CYTOKINE RESPONSE; DERMATITIS; DETERIORATION; DISEASE EXACERBATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; MOUSE; MOUSE MODEL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN DEFECT; SKIN FIBROBLAST; STAPHYLOCOCCUS INFECTION; SYMPTOM; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; CELL PROLIFERATION; FIBROBLAST; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SKIN; STAPHYLOCOCCUS AUREUS;

ANIMALS; BASOPHILS; CELL PROLIFERATION; CHEMOKINES; COCULTURE TECHNIQUES; DERMATITIS, ATOPIC; EOSINOPHILS; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LIGANDS; MAP KINASE SIGNALING SYSTEM; MICE, INBRED BALB C; MODELS, BIOLOGICAL; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; SIGNAL TRANSDUCTION; SKIN; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2;

EID: 84977599363     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2015.77     Document Type: Article

References (40)

1. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
2. Sicherer SH, Leung DY. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2013. J Allergy Clin Immunol 2014; 133: 324-334.
3. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233-246.
4. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123: e808-e814.
5. Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006; 155: 680-687.
6. Matsui K, Wirotesangthong M, Nishikawa A. Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin. Clin Exp Allergy 2007; 37: 615-622.
7. Travers JB, Kozman A, Mousdicas N, Saha C, Landis M, Al-HassaniM et al. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J Allergy Clin Immunol 2010; 125: 146-152.
8. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
9. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, Karin M et al. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc Natl Acad Sci USA 2009; 106: 12873-12878.
10. Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 2013; 133: 988-998.
11. Niebuhr M, Baumert K, Werfel T. TLR-2-mediated cytokine and chemokine secretion in human keratinocytes. Exp Dermatol 2010; 19: 873-877.
12. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165: 5392-5396.
13. Kaesler S, Volz T, Skabytska Y, Koberle M, Hein U, ChenKMet al. Tolllike receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10. J Allergy Clin Immunol 2014; 134: 92-99.
14. Bieneman AP, Chichester KL, Chen YH, Schroeder JT. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion. J Allergy Clin Immunol 2005; 115: 295-301.
15. Irani AM, Huang C, Xia HZ, Kepley C, Nafie A, Fouda ED et al. Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol 1998; 101: 354-362.
16. Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy 2004; 59: 561-570.
17. Karasuyama H, Mukai K, Obata K, Tsujimura Y, Wada T. Nonredundant roles of basophils in immunity. Annu Rev Immunol 2011; 29: 45-69.
18. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010; 125: S73-S80.
19. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008; 38: 709-750.
20. Komiya A, Nagase H, Okugawa S, Ota Y, Suzukawa M, Kawakami A et al. Expression and function of toll-like receptors in human basophils. Int Arch Allergy Immunol 2006; 140: 23-27.
21. Wong CK, Cheung PF, Ip WK, Lam CW. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 2007; 37: 85-96.
22. Qiu HN, Wong CK, Chu IM, Hu S, Lam CW. Muramyl dipeptide mediated activation of human bronchial epithelial cells interacting with basophils: a novel mechanism of airway inflammation. Clin Exp Immunol 2013; 172: 81-94.
23. Wong CK, Hu S, Leung KM, Dong J, He L, Chu YJ et al. NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma. Cell Mol Immunol 2013; 10: 317-329.
24. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 2006; 103: 11736-11741.
25. Choi J, Kim JR, Kim H, Kim YA, Lee HJ, Kim J et al. The atopic dermatitis-like symptoms induced by MC903 were alleviated in JNK1 knockout mice. Toxicol Sci 2013; 136: 443-449.
26. Rebane A, Runnel T, Aab A, Maslovskaja J, Ruckert B, ZimmermannM et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol 2014; 134: 836-847.
27. Ohmori K, Luo Y, Jia Y, Nishida J, Wang Z, Bunting KD et al. IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bonemarrow and by increasing the number of basophil/mast cell progenitors in the spleen. J Immunol 2009; 182: 2835-2841.
28. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008; 2008: t4986.
29. Fukuda S, Midoro K, Kamei T, Gyoten M, Kawano Y, Ashida Y et al. Inhibition of allergic dermal inflammation by the novel imidazopyridazine derivative TAK-427 in a guinea pig experimental model of eczema. J Pharmacol Exp Ther 2002; 303: 1283-1290.
30. James JM, Kagey-Sobotka A, Sampson HA. Patients with severe atopic dermatitis have activated circulating basophils. J Allergy Clin Immunol 1993; 91: 1155-1162.
31. Jenerowicz D, Czarnecka-Operacz M, Silny W. Peripheral blood eosinophilia in atopic dermatitis. Acta Dermatovenerol Alp Pannonica Adriat 2007; 16: 47-52.
32. Lewis SA, Pavord ID, Stringer JR, Knox AJ, Weiss ST, Britton JR. The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults. Chest 2001; 119: 105-114.
33. Wong CK, Leung KM, Qiu HN, Chow JY, Choi AO, Lam CW. Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis. PLoS One 2012; 7: e29815.
34. Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, KaplanDH et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity 2015; 42: 756-766.
35. Sokol CL, Chu NQ, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009; 10: 713-720.
36. Khodoun MV, Orekhova T, Potter C, Morris S, Finkelman FD. Basophils initiate IL-4 production during a memory T-dependent response. J Exp Med 2004; 200: 857-870.
37. Finkelman FD, Madden KB, Morris SC, Holmes JM, Boiani N, Katona IM et al. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anticytokine antibody complexes. J Immunol 1993; 151: 1235-1244.
38. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998; 392: 90-93.
39. Nakashima C, Otsuka A, Kitoh A, Honda T, Egawa G, Nakajima S et al. Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis. J Allergy Clin Immunol 2014; 134: 100-107.
40. Jeon JH, Kim SK, Baik JE, Kang SS, Yun CH, Chung DK et al. Lipoteichoic acid of Staphylococcus aureus enhances IL-6 expression in activated human basophils. Comp Immunol Microbiol Infect Dis 2012; 35: 363-374.